|
|||||
|
|
The pharmacokinetics and safety profiles of belimumab after single subcutaneous and intravenous doses in healthy Japanese volunteers |
|
| Authors: | Y. Shida BPharm N. Takahashi MPharm T. Sakamoto BSc H. Ino MPharm A. Endo PhD T. Hirama MD PhD |
| Affiliation: | 1. Clinical Pharmacology, Medicines Development, Development & Medical Affairs Division, GlaxoSmithKline K.K., , Tokyo, Japan;2. Biomedical Data Science Department, Development & Medical Affairs Division, GlaxoSmithKline K.K., , Tokyo, Japan;3. Immuno‐Inflammation & Ophthalmology, Medicines Development, Development & Medical Affairs Division, GlaxoSmithKline K.K., , Tokyo, Japan |
| Abstract: | |
| Keywords: | belimumab healthy Japanese pharmacokinetics safety |